Search Results - "FUKUDA, Yoshiko"

Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy by Fukuda, Yoshiko, Sakurada, Yoichi, Matsubara, Mio, Kotoda, Yumi, Kasai, Yuka, Sugiyama, Atsushi, Kashiwagi, Kenji

“…Purpose To compare the one-year visual and anatomic outcomes of an as-needed regimen of brolucizumab and aflibercept for polypoidal choroidal vasculopathy…”
Get full text

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation by Shigemoto, Yumi, Sakurada, Yoichi, Fukuda, Yoshiko, Matsubara, Mio, Parikh, Ravi, Kashiwagi, Kenji

“…Brolucizumab is a novel anti-vascular endothelial growth factor agent with clinical trials demonstrating excellent efficacy for neovascular age-related macular…”
Get full text

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy by Wataru, Kikushima, Sugiyama, Atsushi, Yoneyama, Seigo, Matsubara, Mio, Fukuda, Yoshiko, Parikh, Ravi, Sakurada, Yoichi

“…We report 5-year visual and anatomical outcomes after combination therapy of photodynamic therapy (PDT) and intravitreal injection of ranibizumab or…”
Get full text

Characteristics of intermediate age-related macular degeneration with hyperreflective foci by Kikushima, Wataru, Sakurada, Yoichi, Sugiyama, Atsushi, Yoneyama, Seigo, Matsubara, Mio, Fukuda, Yoshiko, Shijo, Taiyo, Kotoda, Yumi, Fragiotta, Serena, Kashiwagi, Kenji

“…Hyperreflective foci (HRF) are the findings observed in optical coherence tomography (OCT) in several retinal diseases and are believed to be associated with…”
Get full text

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy by Fukuda, Yoshiko, Sakurada, Yoichi, Matsubara, Mio, Hasebe, Yuka, Sugiyama, Atsushi, Kikushima, Wataru, Kashiwagi, Kenji

“…We compared the short-term outcomes between 3-monthly aflibercept and brolucizumab injections for treatment-naïve polypoidal choroidal vasculopathy (PCV). A…”
Get full text

Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results by Matsubara, Mio, Sakurada, Yoichi, Sugiyama, Atsushi, Fukuda, Yoshiko, Parikh, Ravi, Kashiwagi, Kenji, Falcão, Manuel Alberto de Almeida e Sousa

“…We investigated whether response to photodynamic therapy (PDT) with intravitreal aflibercept injection (IAI) for polypoidal choroidal vasculopathy (PCV)…”
Get full text

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result by Kikushima, Wataru, Sakurada, Yoichi, Fukuda, Yoshiko, Matsubara, Mio, Kotoda, Yumi, Sugiyama, Atsushi, Kashiwagi, Kenji

“…We aimed to investigate whether a treat-and-extend regimen of intravitreal brolucizumab (6.0 mg/0.05 mL) is effective for eyes with exudative age-related…”
Get full text

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy by Kikushima, Wataru, Sugiyama, Atsushi, Yoneyama, Seigo, Matsubara, Mio, Fukuda, Yoshiko, Parikh, Ravi, Sakurada, Yoichi

“…[This corrects the article DOI: 10.1371/journal.pone.0229231.]…”
Get full text

Distinct characteristics of central serous chorioretinopathy according to gender by Yoneyama, Seigo, Fukui, Ayumi, Sakurada, Yoichi, Terao, Nobuhiro, Shijo, Taiyo, Kusada, Natsuki, Sugiyama, Atsushi, Matsubara, Mio, Fukuda, Yoshiko, Kikushima, Wataru, Parikh, Ravi, Mabuchi, Fumihiko, Sotozono, Chie, Kashiwagi, Kenji

“…To investigate the differences in clinical and genetic characteristics between males and females with central serous chorioretinopathy (CSC). Consecutive 302…”
Get full text

Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital by Sakagami, Toru, Kawano, Takaki, Yamashita, Kohei, Yamada, Eio, Fujino, Noritomo, Kaeriyama, Makoto, Fukuda, Yoshiko, Nomura, Nobuhiko, Mitsuyama, Junichi, Suematsu, Hiroyuki, Watanabe, Hiroki, Asai, Nobuhiro, Koizumi, Yusuke, Yamagishi, Yuka, Mikamo, Hiroshige

“…We compared the susceptibility of six commercially available antifungal agents (fluconazole, itraconazole, voriconazole, caspofungin, micafungin, and…”
Get full text

Mid-Term Results of Ab Interno Trabeculectomy among Japanese Glaucoma Patients by Kitamura, Kazuyoshi, Fukuda, Yoshiko, Hasebe, Yuka, Matsubara, Mio, Kashiwagi, Kenji

“…The evaluation of ab interno trabeculectomy, referred to as trabectome , among Japanese patients is insufficient. Japanese patients who underwent trabectome at…”
Get full text

Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy by Yoneyama, Seigo, Sakurada, Yoichi, Kikushima, Wataru, Sugiyama, Atsushi, Matsubara, Mio, Fukuda, Yoshiko, Tanabe, Naohiko, Parikh, Ravi, Mabuchi, Fumihiko, Kashiwagi, Kenji, Iijima, Hiroyuki

“…In the present study, we investigated the association between susceptible genetic variants to age-related macular degeneration (AMD) and response to as-needed…”
Get full text

Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy by Kimura, Misa, Sakurada, Yoichi, Fukuda, Yoshiko, Matsubara, Mio, Kotoda, Yumi, Kasai, Yuka, Sugiyama, Atsushi, Kikushima, Wataru, Tsuru, Daphne Viel, Kashiwagi, Kenji

“…We compared 12-month outcomes of eyes with polypoidal choroidal vasculopathy (PCV) with or without complete regression of polyps observed one month after three…”
Get full text

Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration by Shijo, Taiyo, Sakurada, Yoichi, Yoneyama, Seigo, Kikushima, Wataru, Sugiyama, Atsushi, Matsubara, Mio, Fukuda, Yoshiko, Mabuchi, Fumihiko, Kashiwagi, Kenji

“…We investigated whether polygenic risk score (PRS) was associated with one-year outcome of as-needed aflibercept therapy for exudative age-related macular…”
Get full text

Repeated Measurements Are Necessary for Evaluating Accurate Diurnal Rhythm Using a Self-Intraocular Pressure Measurement Device by Shigemoto, Yumi, Hasebe, Yuka, Kitamura, Kazuyoshi, Fukuda, Yoshiko, Sakamoto, Masako, Matsubara, Mio, Minaguchi, Shinya, Kashiwagi, Kenji

“…To investigate how many tests need to be performed to adequately assess intraocular pressure (IOP) diurnal change using a self-measuring rebound tonometer…”
Get full text

Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves’ disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission by Konishi, Toshiaki, Okamoto, Yasuyuki, Ueda, Miki, Fukuda, Yoshiko, Harusato, Ichiko, Tsukamoto, Yuka, Hamada, Noboru

“…According to the guideline issued by the Japan Thyroid Association in 2006 for treatment of Graves’ disease, discontinuing antithyroid drug (ATD) therapy is…”
Get full text

Bactericidal activity of garenoxacin against in vitro biofilm formed by nontypeable Haemophilus influenzae by Takahata, Masahiro, Sugiura, Yoko, Shinmura, Yuko, Fukuda, Yoshiko, Nomura, Nobuhiko

“…Abstract Using β -lactamase-negative ampicillin (ABPC)-susceptible (BLNAS) and β -lactamase-negative ABPC-resistant (BLNAR) nontypeable Haemophilus influenzae…”
Get full text

Development of Tumor-induced Osteomalacia in a Subcutaneous Tumor, Defined by Venous Blood Sampling of Fibroblast Growth Factor-23 by Ogura, Eriko, Kageyama, Kazunori, Fukumoto, Seiji, Yagihashi, Norito, Fukuda, Yoshiko, Kikuchi, Toru, Masuda, Mitsuo, Suda, Toshihiro

“…A 25-year-old man with severe lumbago was referred to our department for further evaluation. Serum phosphate and TmP/GFR levels were decreased. Physical…”
Get full text

In Vitro and in Vivo Activities of T-705 and Oseltamivir against Influenza Virus by Takahashi, Kazumi, Furuta, Yousuke, Fukuda, Yoshiko, Kuno, Masako, Kamiyama, Tomoko, Kozaki, Kyo, Nomura, Nobuhiko, Egawa, Hiroyuki, Minami, Shinzaburo, Shiraki, Kimiyasu

“…T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide) has a potent and selective inhibitory activity against influenza virus. We studied the effects of an…”
Get full text

Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentration by Fukuda, Yoshiko, Takahata, Masahiro, Mitsuyama, Junichi

“…We compared the antibacterial effects and the emergence of resistance to tosufloxacin or levofloxacin for Streptococcus pneumoniae by simulating the serum…”
Get full text